From nuclear medicine to orthopaedics: Accentus Medical’s growing boundaries
This article was originally published in Clinica
Orthopaedic coating specialist Accentus Medical started life as part of the UK’s leading atomic energy organisation. Now it is striving to take its coatings and other surface modification technologies beyond the orthopaedics industry to the global medtech market. Joseph Harvey met the company’s senior management team Philip Agg and Martin Pickford to find out how Accentus’s roots in the nuclear industry have grown into a burgeoning medical device technology business
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals